QIAGEN

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QIAGEN and other ETFs, options, and stocks.

About QGEN

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. 

CEO
Thierry L. Bernard
CEOThierry L. Bernard
Employees
5,765
Employees5,765
Headquarters
Venlo, Limburg
HeadquartersVenlo, Limburg
Founded
1996
Founded1996
Employees
5,765
Employees5,765

QGEN Key Statistics

Market cap
9.61B
Market cap9.61B
Price-Earnings ratio
23.91
Price-Earnings ratio23.91
Dividend yield
0.56%
Dividend yield0.56%
Average volume
1.51M
Average volume1.51M
High today
$45.27
High today$45.27
Low today
$44.24
Low today$44.24
Open price
$44.49
Open price$44.49
Volume
1.25M
Volume1.25M
52 Week high
$51.88
52 Week high$51.88
52 Week low
$37.63
52 Week low$37.63

Stock Snapshot

The current QIAGEN(QGEN) stock price is $44.32, with a market capitalization of 9.61B. The stock trades at a price-to-earnings (P/E) ratio of 23.91 and offers a dividend yield of 56.4%.

As of 2025-11-15, QIAGEN(QGEN) stock has fluctuated between $44.24 and $45.27. The current price stands at $44.32, placing the stock +0.2% above today's low and -2.1% off the high.

The QIAGEN(QGEN)'s current trading volume is 1.25M, compared to an average daily volume of 1.51M.

In the last year, QIAGEN(QGEN) shares hit a 52-week high of $51.88 and a 52-week low of $37.63.

In the last year, QIAGEN(QGEN) shares hit a 52-week high of $51.88 and a 52-week low of $37.63.

QGEN News

TipRanks 3d
Qiagen price target lowered to EUR 46 from EUR 50 at Berenberg

Berenberg analyst Harry Gillis lowered the firm’s price target on Qiagen (QGEN) to EUR 46 from EUR 50 and keeps a Buy rating on the shares. Meet Your ETF AI An...

TipRanks 6d
Qiagen’s Hold Rating: Solid Q3 Performance Overshadowed by Uncertainties and Mixed Growth Outlook

TD Cowen analyst Daniel Brennan maintained a Hold rating on Qiagen yesterday and set a price target of $48.00. Meet Your ETF AI Analyst Discover how TipRanks' E...

Simply Wall St 6d
Could Qiagen's Leadership Change Reveal Shifts in Its Long-Term Growth Priorities?

Qiagen N.V. recently reported third-quarter results, with sales rising to US$532.58 million and net income reaching US$130.04 million, and reaffirmed its full-y...

Could Qiagen's Leadership Change Reveal Shifts in Its Long-Term Growth Priorities?

Analyst ratings

58%

of 24 ratings
Buy
41.7%
Hold
58.3%
Sell
0%

People also own

Based on the portfolios of people who own QGEN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.